Stock ELOX ELOXX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eloxx Pharmaceuticals, Inc.

Equities

ELOX

US29014R2022

Delayed OTC Markets
Other stock markets
 11:21:37 2024-04-26 am EDT 		5-day change 1st Jan Change
0.8 USD +1.91% Intraday chart for Eloxx Pharmaceuticals, Inc. -0.12% -33.33%
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
Mar. 13 Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases CI

Evolution of the average Target Price on Eloxx Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

68eb7e1.plpttk9YLCwGKT0_ZJXNiWHfGIknP7IfQ1j8g96tL00.njIA_xApSmBjYg5dBeyf1iS8fcgRS8oqFTy91Y-eaCLBaCDdOx1NdD9EaA~f23cea05456e22fc5071ab2adaf98eab

Analyst Recommendations on Eloxx Pharmaceuticals, Inc.

Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $30 From $60, Maintains Outperform Rating MT
Oppenheimer Raises Eloxx Pharmaceuticals Price Target to $60 From $55, Maintains Outperform Rating MT
Oppenheimer Adjusts Eloxx Pharmaceuticals' Price Target to $55 From $50, Keeps Outperform Rating MT
Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $50 From $3, Maintains Outperform Rating MT
Piper Sandler Adjusts Eloxx Pharmaceuticals' Price Target to $1.50 from $4, Keeps Overweight Rating MT
HC Wainwright Trims Eloxx Pharmaceuticals Price Target to $0.5 From $1, Maintains Neutral Rating MT
B. Riley Lowers Eloxx Pharmaceuticals' Price Target to $3 from $5 After Revising Cost Capital Assumptions, Keeps Buy Rating MT
Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Price Target MT
HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral Rating MT
HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neutral Rating MT
ELOXX PHARMACEUTICALS : Mizuho Securities Starts Eloxx Pharmaceuticals at Buy With $3.10 Price Target MT
ELOXX PHARMACEUTICALS : B. Riley Starts Eloxx Pharmaceuticals at Buy with $5 PT, Notes Compelling Turnaround Story MT
ELOXX PHARMACEUTICALS : Piper Sandler Adjusts Price Target on Eloxx Pharmaceuticals to $4 From $6, Keeps Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.785 USD
Average target price
30 USD
Spread / Average Target
+3,721.66%
High Price Target
30 USD
Spread / Highest target
+3,721.66%
Low Price Target
30 USD
Spread / Lowest Target
+3,721.66%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eloxx Pharmaceuticals, Inc.

Oppenheimer
Piper Sandler
HC Wainwright
B. Riley
Mizuho Securities

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ELOX Stock
  4. Consensus Eloxx Pharmaceuticals, Inc.